Waldenström's macroglobulinemia
GPTKB entity
Statements (48)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:healthcare_organization
|
| gptkbp:bfsLayer |
4
|
| gptkbp:bfsParent |
gptkb:Rituxan
gptkb:Imbruvica |
| gptkbp:affects |
B cells
|
| gptkbp:associated_with |
gptkb:lymphoplasmacytic_lymphoma
|
| gptkbp:clinical_trial |
gptkb:vaccine
targeted therapies new therapies combination therapies |
| gptkbp:complications |
gptkb:fandom
infections thrombocytopenia hyperviscosity syndrome |
| gptkbp:events |
blood tests
imaging studies regular monitoring symptom management |
| gptkbp:first_described_by |
gptkb:Jan_Waldenström
|
| https://www.w3.org/2000/01/rdf-schema#label |
Waldenström's macroglobulinemia
|
| gptkbp:is_characterized_by |
high levels of Ig M
|
| gptkbp:is_often_used_in |
older adults
|
| gptkbp:occurs_in |
1-3 cases per million per year
|
| gptkbp:public_awareness |
patient advocacy
fundraising efforts raising awareness |
| gptkbp:related_to |
Ig M monoclonal gammopathy
|
| gptkbp:research_focus |
biomarkers
genetic mutations treatment outcomes |
| gptkbp:risk_factor |
autoimmune diseases
family history exposure to certain chemicals |
| gptkbp:scholarships |
gptkb:Educational_Institution
gptkb:charity counseling services support groups |
| gptkbp:social_responsibility |
variable
blood tests bone marrow biopsy |
| gptkbp:symptoms |
fatigue
weight loss night sweats neuropathy |
| gptkbp:treatment |
variable
monoclonal antibodies chemotherapy plasma exchange |